Tamper evident cap with RFID for syringes

Patent metadata

Field	Value
Publication number	US-12171992-B2
Application number	US-202117235909-A
Country	US
Kind code	B2
Filing date	Apr 20, 2021
Priority date	Nov 28, 2018
Publication date	Dec 24, 2024
Grant date	Dec 24, 2024

Abstract

A syringe assembly includes a syringe and a tamper evident cap disposed over a Luer connection of the syringe, the tamper evident cap having a main body that defines a proximal end defining an opening, a distal end opposite the proximal end, an outer surface, and an inner surface opposite the outer surface that defines a passage to receive a tip cap and the Luer connection, where the tamper evident cap is spaced from the tip cap. The main body defines a frangible connection between the proximal and distal ends thereof. The frangible connection can break under a force applied to the distal end of the tamper evident cap such that the proximal end of the tamper evident cap remains engaged with the syringe when the frangible connection breaks. An RFID tag is disposed on the syringe and has an integrated circuit and an antenna configured to send/receive signals between an RFID reader.

First claim

What is claimed is:

1. A syringe assembly, comprising:
a syringe having a barrel body that extends from a proximal end to a distal end and defines a chamber extending along an axial direction therethrough, and a Luer connection extending from the distal end along the axial direction and defining an outlet in fluid communication with the chamber, wherein the chamber contains a material;
a plunger received within the chamber of the syringe to create a fluid seal within the barrel body;
a tip cap defining a central passage configured to receive a portion of the Luer connection such that the tip cap creates a fluid seal over the outlet;
a tamper evident cap disposed over the Luer connection, the tamper evident cap having a main body that defines a proximal end defining an opening, a distal wall opposite the proximal end along the axial direction, an outer surface, and an inner surface opposite the outer surface that defines a passage configured to receive the tip cap and the Luer connection, wherein the tamper evident cap is spaced from the tip cap, the main body further defining a frangible connection between the proximal and distal ends of the main body; and
a radio-frequency identification (RFID) tag disposed on the syringe and configured to receive and store data related to the syringe assembly,
wherein the RFID tag includes an integrated circuit, configured to store electronic information thereon, and an antenna operatively connected to the integrated circuit and configured to receive a signal from an RFID reader to cause transmission of at least part of the electronic information from the integrated circuit, and
wherein the frangible connection is configured to break under a force applied to the distal end of the tamper evident cap such that the proximal end of the tamper evident cap is configured to remain engaged with the syringe when the frangible connection breaks.

2. The syringe assembly of claim 1 , wherein the distal wall of the tamper evident cap closes a distal end of the tamper evident cap.

3. The syringe assembly of claim 1 , wherein the distal wall of the tamper evident cap partially closes a distal end of the tamper evident cap.

4. The syringe assembly of claim 1 , further comprising:
a film shrink-wrapped over the proximal end of the tamper evident cap and at least a portion of the syringe,
wherein the film includes the RFID tag.

5. The syringe assembly of claim 4 , wherein the film includes a color-coded portion that comprises a color selected from a plurality of colors that each correspond to a different material.

6. The syringe assembly of claim 5 , wherein the color of the color-coded portion corresponds to the material in accordance with ASTM D 4774 .

7. The syringe assembly of claim 4 , wherein the film is adhesive-bonded to the tamper evident cap.

8. The syringe assembly of claim 4 , wherein the film is adhesive-bonded to the syringe.

9. The syringe assembly of claim 4 , wherein the proximal end of the main body includes a plurality of external ribs extending radially outwards from the outer surface and configured to secure the film to the tamper evident cap.

10. The syringe assembly of claim 1 , wherein the proximal end of the main body includes a plurality of internal ribs extending radially inwards from the inner surface and configured to form an interference fit with the Luer connection.

11. The syringe assembly of claim 1 , wherein the frangible connection comprises a plurality of frangible bridges positioned circumferentially around the main body.

12. The syringe assembly of claim 1 , wherein the fluid seal over the outlet is not compromised when the tamper evident cap is disposed over the Luer connection or when the frangible connection is broken.

13. The syringe assembly of claim 1 , wherein the RFID tag is a passive RFID tag and is configured to receive an electronic signal from the RFID reader to initiate transmission of the at least part of the electronic information.

14. The syringe assembly of claim 1 , wherein the RFID tag is configured to operate at a frequency between 300 MHz and 3000 MHz.

15. The syringe assembly of claim 1 , wherein the electronic information includes at least one of a product identifier, a serial number, a lot number, or an expiration date.

16. The syringe assembly of claim 1 , wherein the material includes an active ingredient selected from a group consisting of an opioid, benzodiazepine, α2-adrenergic receptor agonist, beta blocker, morphine, hydromorphone, hydrocodone, oxycodone, oxymorphone, codeine, buprenorphine, naloxone, naltrexone, fentanyl, remifentanil, sufentanil, alfentanil, meperidine, rocuronium, vecuronium, midazolam, lorazepam, diazepam, neostigmine, atropine, glycopyrrolate, dexmedetomidine, cisastracurium, ropivacaine, lidocaine, propofol, ketamine, succinylcholine, moxifloxacin, linezolid, levofloxacin, levetiracetam, vancomycin, cefepime, aztreonam, cefoxitin, ceftriaxone, cefazolin, cefotaxime, ceftazidime, gentamicin, oxacillin, nafcillin, penicillin, cefuroxime, ticarcillin, clavulanic acid, piperacillin, tazobactam, azithromycin, meropenem, ertapenem, tigecycline, micafungin, metronidazole, fluconazole, itraconazole, posaconazole, heparin, enoxaparin, dalteparin, theophylline, acetaminophen (paracetamol), ibuprofen, acetylcysteine, decitabine, azacitidine, docetaxel, pemetrexed, palonosetron, aprepitant, fosaprepitant, famotidine, amiodarone, nitroglycerin, nicardipine, clevidipine, dobutamine, esmolol, labetalol, metroprolol, somatropin, liraglutide, abaloparatide, semaglutide, teriparatide, degarelix, sumatriptan, epinephrine, ephedrine, vasopressin, methotrexate, testosterone, and hydroxyprogesterone.

17. A method of labeling a syringe assembly, the method comprising:
providing a label configured to be affixed to a syringe, the label including a radio-frequency identification (RFID) tag, the RFID tag further having an integrated circuit and an antenna operatively connected to the integrated circuit;
transmitting a first set of data to the RFID tag and storing the first set of data in a memory of the integrated circuit of the RFID tag;
verifying the first set of data on the RFID tag; and
transmitting a second set of data to the RFID tag and storing the second set of data in the integrated circuit, the second set of data being different from the first set of data.

18. The method of claim 17 , wherein the label is placed in electronic connection with an RFID reader, and the first set of data and the second set of data are electronically transmitted by sending a first and second signal, respectively, from the RFID reader to the RFID tag.

19. The method of claim 18 , wherein verifying the first set of data comprises receiving the first set of data from the RFID tag by the RFID reader and performing a comparison of the received first set of data with a control set of data.

20. The method of claim 17 , wherein transmitting the first set of data includes transmitting a product identifier and a serial number to the RFID tag, and transmitting the second set of data includes transmitting a lot number and an expiration date to the RFID tag.

21. The method of claim 17 , further comprising affixing the label to the syringe after the step of transmitting the first set of data but before the step of transmitting the second set of data.

Assignees

• Fresenius Kabi Usa Llc

Inventors

• Murray Christopher J
• Ferraro Anthony
• Ju Gang
• Speek Robert

Classifications

• B65B3/003

  Filling medical containers such as ampoules, vials, syringes or the like · CPC title

• A61M2205/584

  having a color code · CPC title

• A61J1/2096

  Combination of a vial and a syringe for transferring or mixing their contents · CPC title

• A61M2005/3104

  Caps for syringes without needle · CPC title

• A61M2005/312

  comprising sealing means, e.g. severable caps, to be removed prior to injection by, e.g. tearing or twisting · CPC title